Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: Report from the Radiation Therapy Oncology Group

Radiation Therapy ◽

Growth Factor ◽

Prognostic Value ◽

Radiation Therapy Oncology Group ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Oncology Group ◽

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.09.047 ◽

2005 ◽

Vol 62 (2) ◽

pp. 309-317 ◽

Cited By ~ 95

Author(s):

Arnab Chakravarti ◽

Kathryn Winter ◽

Chin-Lee Wu ◽

Donald Kaufman ◽

Elizabeth Hammond ◽

...

Keyword(s):

Radiation Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Radiation Therapy Oncology Group ◽

Growth Factor Receptor ◽

Complete Response ◽

Oncology Group ◽

Her 2 ◽

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2011.04.060 ◽

2011 ◽

Vol 2011 ◽

pp. 141-143

Author(s):

J. Uhm

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Free Survival ◽

The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

Radiation Oncology ◽

10.1186/1748-717x-3-32 ◽

2008 ◽

Vol 3 (1) ◽

Cited By ~ 29

Author(s):

Prakash Chinnaiyan ◽

Meihua Wang ◽

Amyn M Rojiani ◽

Philip J Tofilon ◽

Arnab Chakravarti ◽

...

Keyword(s):

Radiation Therapy ◽

Prognostic Value ◽

Radiation Therapy Oncology Group ◽

Newly Diagnosed ◽

Oncology Group ◽

Nestin Expression ◽

Newly Diagnosed Glioblastoma

How Fine a Slice: Treatment of Newly Diagnosed Glioblastoma With an Epidermal Growth Factor Receptor Variant III Peptide Vaccine

Journal of Clinical Oncology ◽

10.1200/jco.2010.34.0588 ◽

2011 ◽

Vol 29 (17) ◽

pp. e517-e518 ◽

Cited By ~ 3

Author(s):

Marc C. Chamberlain

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Peptide Vaccine ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Faculty Opinions recommendation of Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6040956.7559059 ◽

2010 ◽

Author(s):

Joachim Baehring ◽

Kevin Becker

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Free Survival ◽

Faculty Opinions recommendation of Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6040956.6344054 ◽

2010 ◽

Author(s):

Marc Chamberlain

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Free Survival ◽

Faculty Opinions recommendation of Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6040956.6057054 ◽

2010 ◽

Author(s):

Wolfgang Wick ◽

Markus Weiler

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Free Survival ◽

Faculty Opinions recommendation of Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6040956.11999055 ◽

2011 ◽

Author(s):

Minesh Mehta ◽

Deepak Khuntia

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Newly Diagnosed ◽

Peptide Vaccination ◽

Free Survival ◽

P76.54 Prognostic Value of Radiotherapy Pattern for Late-Stage Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinomas

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1111 ◽

2021 ◽

Vol 16 (3) ◽

pp. S611

Author(s):

Z. Li ◽

Y. Zhang

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Late Stage ◽

Prognostic Value ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Egfr Mutant ◽

Lung Adenocarcinomas

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2003.09.043 ◽

2004 ◽

Vol 58 (2) ◽

pp. 561-566 ◽

Cited By ~ 85

Author(s):

Jesper Grau Eriksen ◽

Torben Steiniche ◽

Jon Askaa ◽

Jan Alsner ◽

Jens Overgaard

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Prognostic Value ◽

Treatment Time ◽

Growth Factor Receptor ◽

Squamous Cell Carcinomas ◽

Tumor Differentiation ◽

Overall Treatment Time ◽